Kurm Pharma ApS
CVR 39181274 · Private limited company (ApS) · Active · Low risk
Kurm Pharma ApS is a Private limited company (ApS), founded on , based in Vejle. The company is registered in the industry fremstilling af parfume, hårshampoo, tandpasta mv.. Our model estimates a bankruptcy risk of 0.9% over the next 12 months, which is 0.6 times the average for Danish companies. 8 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 1.8m and a net result of DKK -2.0m. CEO: Jacob Gjelstrup, Jesper Gjelstrup.
Bankruptcy risk for Kurm Pharma ApS
0.6 × the average (1.41%) · higher risk than 69% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 39181274
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (8 years)
- Address
- Ferrarivej 12
7100 Vejle - Municipality
- Vejle
- Industry
- Fremstilling af parfume, hårshampoo, tandpasta mv. (204200)
Bankruptcies in the industry: Fremstilling af parfume, hårshampoo, tandpasta mv. - Share capital
- DKK 50k
- Auditor
- Grant Thornton, Godkendt Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 8 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 35.5% |
| Current ratio | 155% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 11 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK -2.6m | DKK 331k |
| Net profit | DKK -2.0m | DKK 602k |
| Equity | DKK 1.8m | DKK 4.1m |
| Total assets | DKK 5.1m | DKK 6.9m |
| Cash | DKK 32k | – |
| Short-term debt | DKK 3.3m | – |
| Avg. employees | 0 | – |
Latest annual report: Reporting class B · auditor's statement: Erklæring om udvidet gennemgang · Grant Thornton, Godkendt Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 124 | ||
| 1 Jan 2024 – 31 Dec 2024 | 114 | ||
| 1 Jan 2023 – 31 Dec 2023 | 116 | ||
| 1 Jan 2022 – 31 Dec 2022 | 90 | ||
| 1 Jan 2021 – 31 Dec 2021 | 178 | ||
| 1 Jan 2020 – 31 Dec 2020 | 84 | ||
| 1 Jan 2019 – 31 Dec 2019 | 113 | ||
| 18 Dec 2017 – 31 Dec 2018 | 148 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Jacob Gjelstrup | Current | |
| CEO | Jesper Gjelstrup | Current | |
| Board | Jacob Gjelstrup | Current | |
| Board | Jesper Gjelstrup | Current | |
| Board | Steen Nordstrøm | Current | |
| Board | Allan Christensen | Current | |
| Board | Johannes Gjelstrup | ||
| Board | Peter Vammen | ||
| Board | Steen Nordstrøm | ||
| Owner (100%) | Fitzrovia ApS | Current | |
| Owner (33%) | PIMLICO ApS | ||
| Owner (33%) | ROYSTON ApS | ||
| Owner (20%) | SENA HOLDING ApS | ||
| Owner (50%) | PIMLICO ApS | ||
| Owner (50%) | ROYSTON ApS | ||
| Auditor | Grant Thornton, Godkendt Revisionspartnerselskab | Current | |
| Auditor | Kvist & Jensen SR, Grenå A/S | ||
| Auditor | Kvist & Jensen Statsautoriseret Revisionspartnerselskab | ||
| Founder | PIMLICO ApS | Current | |
| Founder | ROYSTON ApS | Current | |
| Founder | SENA HOLDING ApS | Current |
The CEOs' other companies
Jacob Gjelstrup – 3 other companies
- DIAFARM A/S Active
- GC & C ApS - Gjelstrup Consulting & Capital Fusioneret
- United Group Manufacturing A/S Active
Jesper Gjelstrup – 4 other companies
- DIAFARM A/S Active
- Fitzrovia ApS Active
- GC & C ApS - Gjelstrup Consulting & Capital Fusioneret
- United Group Manufacturing A/S Active
Address history (0 moves)
| Ferrarivej 12, 7100 Vejle |
Other companies at the same address
- AKTIESELSKABET AF DECEMBER 2010 Bankrupt
- DMS-GROUP ApS Bankrupt
- BrandMac ApS Active
- DIAFARM A/S Active
- DMS HOLDING ApS Compulsorily dissolved
- DUOTEX A/S Fusioneret
- Euro Brand Shop ApS Fusioneret
- Fitzrovia ApS Active
- GC & C ApS - Gjelstrup Consulting & Capital Fusioneret
- MODU Valves A/S Active
- United Group Manufacturing A/S Active
Similar companies in Vejle
- Canne ApS Give
- United Group Manufacturing A/S Vejle
- ORGANIC BEAUTY APS Jelling
- DIAFARM A/S Vejle
- GC & C ApS - Gjelstrup Consulting & Capital Vejle
- 2 CAREBY ApS Jelling
Questions and answers about Kurm Pharma ApS
Has Kurm Pharma ApS gone bankrupt?
No, Kurm Pharma ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Kurm Pharma ApS?
Our model estimates a bankruptcy risk of 0.9% over the next 12 months (low risk), which is 0.6 times the average for Danish companies.
Who is the CEO of Kurm Pharma ApS?
Jacob Gjelstrup, Jesper Gjelstrup are the CEOs of Kurm Pharma ApS.
Who is the auditor of Kurm Pharma ApS?
Kurm Pharma ApS most recently used Grant Thornton, Godkendt Revisionspartnerselskab.
When was Kurm Pharma ApS founded?
Kurm Pharma ApS was founded on 18 December 2017.
What is the equity of Kurm Pharma ApS?
Equity was DKK 1.8m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.